[{"Assets_0_Q1_USD":1350034000.0,"EarningsPerShareBasic_1_Q1_USD":0.38,"EarningsPerShareDiluted_1_Q1_USD":0.37,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":25022000.0,"NetIncomeLoss_1_Q1_USD":10657000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":5592000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":202064000.0,"StockholdersEquity_0_Q1_USD":642628000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":28573000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":28008000.0,"Ticker":"CNMD","CIK":"816956","name":"CONMED CORP","OfficialName":"CONMED Corporation Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4404922313.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20180426"}]